Ellenbecker Investment Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$856K Sell
714
-34
-5% -$34.7K 0.1% 55
2026
Q1
$689K Sell
748
-31
-4% -$31.4K 0.09% 64
2025
Q4
$838K Buy
779
+377
+94% +$360K 0.12% 50
2025
Q3
$307K Buy
402
+93
+30% +$69.2K 0.05% 94
2025
Q2
$242K Buy
309
+29
+10% +$22.5K 0.04% 105
2025
Q1
$232K Sell
280
-8
-3% -$6.66K 0.04% 105
2024
Q4
$223K Buy
288
+26
+10% +$21.5K 0.04% 109
2024
Q3
$232K Sell
262
-170
-39% -$153K 0.04% 103
2024
Q2
$391K Buy
432
+142
+49% +$114K 0.08% 74
2024
Q1
$226K Buy
+290
New +$206K 0.05% 101
2023
Q4
Sell
-431
Closed -$231K 103
2023
Q3
$231K Buy
+431
New +$222K 0.06% 95

Other funds holding LLY

Ellenbecker Investment Group's LLY Position: Q2 2026 in Review

Ellenbecker Investment Group reduced its Eli Lilly (LLY) stake by 4.5% in Q2 2026, selling an estimated $34.7K and leaving 714 shares worth $856K. The position accounts for 0.1% of the portfolio, ranked #55.

Ellenbecker Investment Group first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ellenbecker Investment Group held 714 shares of Eli Lilly worth $856K as of Q2 2026.
  • Ellenbecker Investment Group sold 34 Eli Lilly shares in Q2 2026, an estimated $34.7K.
  • Eli Lilly made up 0.1% of Ellenbecker Investment Group's portfolio in Q2 2026, its #55 holding.
  • Ellenbecker Investment Group first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
  • 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ellenbecker Investment Group's 13F filing for Q2 2026, filed 27 Jul 2026.